Author

Yang Hu

Institutions: Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Peking University Third Hospital, Hubei Cancer Hospital, Huazhong University of Science and Technology

Observed institutions: Shanxi Medical University, Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Peking University Third Hospital, Hubei Cancer Hospital, Huazhong University of Science and Technology

ORCID: 0000-0002-1624-6895

Observed ORCID: 0000-0002-1624-6895

OpenAlex ID: A5114973151

Advancement Opportunities and Endeavor of Innovative Targeted Therapies for Small Cell Lung Cancer

2025 · Wei Ouyang, Ziyao Xu, et al. · International Journal of Biological Sciences · 9

Anisomycin alleviates cognitive impairments and pathological features in 3xTg-AD mice

2024 · Juan-Juan Jiao, Yang Hu, et al. · Neuropharmacology · 4

Global burden and cross-country inequalities of gallbladder and biliary tract cancer in adults aged 45 years and older from 1990 to 2021: population-based study

2025 · Simeng Lei, Yangkai Fu, et al. · Frontiers in Oncology

Efficacy of cyclophosphamide for skin fibrosis in systemic sclerosis: a systematic review and single-arm meta-analysis

2025 · Xin Tian, PengJiao An, et al. · European Journal of Clinical Pharmacology

A 15-Gene prognostic signature with TFAP2B functioning in Platinum Resistance of Ovarian Carcinoma

2024 · Yang Hu, Ping Wang, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 5

Citation count: 13

H-index: 2

I10-index: